Business Meeting

Partners

To support our cause, we seek partners that want to follow this path with us together. We are interested in building relationships with institutional and strategic investors, medical technology companies and associations. We strive to collaborate with you, in order to execute on our – and your - vision. Your investment opportunities are our programs, developed by a team of experts from academia and industry. Please contact us.

EnClear Therapies Announces Series A Financing with Peter Thiel, Amgen Ventures, 20/20 HealthCare Partners, Global Health Sciences Fund (Quark Venture LP and GF Securities), Christian Angermayer’s Presight Capital, Tachyon Ventures and Dolby Ventures. 

Thiel.png
Amgen+Ventures+logo.png
Presight.png
2020 healthcare logo.png
Sanford Bioscience
GHS Fund Logo FINAL.jpg
Bioverge- Expanded Logo-1.png
Menu_logo.png
tachyon+ventures+logo+black+transparent.